
Thyroid Gland Disorder Treatment
Description
Global Thyroid Gland Disorder Treatment Market to Reach US$4.1 Billion by 2030
The global market for Thyroid Gland Disorder Treatment estimated at US$3.2 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hypothyroidism, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Hyperthyroidism segment is estimated at 3.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$854.4 Million While China is Forecast to Grow at 4.0% CAGR
The Thyroid Gland Disorder Treatment market in the U.S. is estimated at US$854.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$643.0 Million by the year 2030 trailing a CAGR of 4.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
Global Thyroid Gland Disorder Treatment Market - Key Trends and Drivers Summarized
How Is Thyroid Gland Disorder Treatment Evolving?
Thyroid gland disorder treatment has become increasingly advanced as more people worldwide are diagnosed with conditions like hypothyroidism, hyperthyroidism, and thyroid cancer. The most common treatments for hypothyroidism involve hormone replacement therapy (HRT) using synthetic levothyroxine, which helps normalize thyroid hormone levels. Hyperthyroidism, on the other hand, can be treated through a combination of antithyroid medications, radioactive iodine therapy, or surgery, depending on the severity of the condition. Recent developments in personalized medicine and targeted therapies are offering patients more effective, customized treatments. With autoimmune thyroid disorders on the rise, there has been growing research into immunomodulatory therapies that could offer new solutions for conditions like Hashimoto’s and Graves’ disease.
What Segments Shape the Thyroid Gland Disorder Treatment Market?
Disorder types include hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer. Treatment types range from hormone replacement therapy and antithyroid medications to radioactive iodine therapy and surgical interventions such as thyroidectomy. Increasingly, biologics and targeted therapies are being developed for more complex cases like thyroid cancer. End-users include hospitals, clinics, and specialized endocrinology centers. The rising use of telemedicine platforms for monitoring and adjusting thyroid treatments is also transforming the way care is delivered, especially in remote or underserved areas. Geographically, the market is expanding rapidly in regions like Asia-Pacific due to improving healthcare infrastructure and increased awareness of thyroid health.
What Are the Latest Trends in Thyroid Gland Disorder Treatment?
Innovations in thyroid gland disorder treatment are primarily focused on improving the effectiveness of therapies and minimizing side effects. Advances in surgical techniques, such as robotic-assisted thyroidectomy, have made surgery safer and less invasive. Radioactive iodine therapy has also seen improvements, with more precise dosing options that target affected tissue while sparing healthy cells. Additionally, hormone replacement therapies are becoming more tailored, with some patients receiving combination treatments of T4 and T3 for better symptom control. Personalized medicine is another growing trend, with genomic testing allowing for customized treatment plans, especially in cases of thyroid cancer. Telemedicine is also becoming more popular for follow-up care and treatment monitoring, allowing patients to receive care from the comfort of their homes.
What Factors Are Driving Growth in the Thyroid Gland Disorder Treatment Market?
The growth in the thyroid gland disorder treatment market is driven by several factors, including the increasing prevalence of thyroid disorders, rising awareness of thyroid health, and advancements in medical technology. The aging population and higher incidence of autoimmune thyroid disorders, particularly among women, are significant growth drivers. Increased access to healthcare in developing countries is expanding the market for thyroid treatments, while innovations in surgical techniques and personalized therapies are improving patient outcomes. The growing use of telemedicine for managing chronic thyroid conditions is also transforming the market, making treatments more accessible and improving patient compliance. Additionally, the increasing investment in research and development of new therapies for thyroid cancer is driving further market expansion.
SCOPE OF STUDY:The report analyzes the Thyroid Gland Disorder Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Hypothyroidism, Hyperthyroidism); Administration Type (Oral, Intravenous, Other Administration Types)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 44 Featured) -
- Abbott Laboratories, Inc.
- AbbVie, Inc.
- Amgen, Inc.
- GlaxoSmithKline PLC
- Lannett Company, Inc.
- Merck & Co., Inc.
- Mylan NV
- Pfizer, Inc.
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Global Economic Update
- Thyroid Gland Disorder Treatment – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Prevalence of Thyroid Disorders Expands Addressable Market for Treatment
- Advances in Precision Medicine and Personalized Therapies Propel Growth in Thyroid Disorder Treatment
- Increasing Use of Hormone Replacement Therapy for Hypothyroidism Spurs Market Adoption
- Growing Focus on Minimally Invasive Surgery for Thyroid Gland Disorders Strengthens Market
- Rising Demand for Radioactive Iodine Therapy in Hyperthyroidism Treatment Expands Market Opportunities
- Technological Innovations in Robotic Thyroid Surgery Propel Adoption in Surgical Treatment
- Increasing Incidence of Thyroid Cancer Drives Demand for Advanced Treatment Modalities
- Surge in Use of Biologics and Monoclonal Antibodies in Targeted Thyroid Disorder Treatment
- Growing Use of Artificial Intelligence in Thyroid Disease Diagnosis and Treatment Strengthens Business Case
- Rising Awareness of Autoimmune Thyroid Disorders Spurs Demand for Early Treatment Options
- Growing Application of Telemedicine for Thyroid Disease Management Accelerates Market Adoption
- Rising Focus on Nutritional Interventions and Supplements in Thyroid Disorder Management
- Growing Adoption of Combination Therapies for Complex Thyroid Disorders Expands Market
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Thyroid Gland Disorder Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Thyroid Gland Disorder Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Thyroid Gland Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Hypothyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Hypothyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Hypothyroidism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Hyperthyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Hyperthyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Hyperthyroidism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Intravenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Intravenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Intravenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Other Administration Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Other Administration Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Other Administration Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Thyroid Gland Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 20: USA Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: USA 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 23: USA Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 24: USA Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: USA 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- CANADA
- TABLE 26: Canada Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: Canada 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 29: Canada Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 30: Canada Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: Canada 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- JAPAN
- Thyroid Gland Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 32: Japan Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: Japan 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 35: Japan Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 36: Japan Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: Japan 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- CHINA
- Thyroid Gland Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 38: China Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: China Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: China 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 41: China Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: China Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: China 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- EUROPE
- Thyroid Gland Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 44: Europe Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Thyroid Gland Disorder Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: Europe 15-Year Perspective for Thyroid Gland Disorder Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: Europe 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 50: Europe Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Europe Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Europe 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- FRANCE
- Thyroid Gland Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 53: France Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: France Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: France 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 56: France Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: France Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: France 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- GERMANY
- Thyroid Gland Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 59: Germany Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Germany 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 62: Germany Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Germany Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: Germany 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- ITALY
- TABLE 65: Italy Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Italy 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 68: Italy Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: Italy Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Italy 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Thyroid Gland Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 71: UK Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: UK 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 74: UK Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: UK Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: UK 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Rest of Europe Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: Rest of Europe 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Rest of Europe Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Rest of Europe 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Thyroid Gland Disorder Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Asia-Pacific Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Asia-Pacific 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Asia-Pacific Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Asia-Pacific 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- REST OF WORLD
- TABLE 89: Rest of World Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Rest of World Historic Review for Thyroid Gland Disorder Treatment by Type - Hypothyroidism and Hyperthyroidism Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Rest of World 15-Year Perspective for Thyroid Gland Disorder Treatment by Type - Percentage Breakdown of Value Sales for Hypothyroidism and Hyperthyroidism for the Years 2015, 2025 & 2030
- TABLE 92: Rest of World Recent Past, Current & Future Analysis for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: Rest of World Historic Review for Thyroid Gland Disorder Treatment by Administration Type - Oral, Intravenous and Other Administration Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: Rest of World 15-Year Perspective for Thyroid Gland Disorder Treatment by Administration Type - Percentage Breakdown of Value Sales for Oral, Intravenous and Other Administration Types for the Years 2015, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates